Literature DB >> 12270218

Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells.

Hesso Farhan1, Kristiina Wähälä, Herman Adlercreutz, Heide S Cross.   

Abstract

The high ingestion of soybean products in Asian countries has been suggested to be responsible for a reduced incidence of prostate cancer. The mechanism of action, however, is unknown. Our data demonstrate that genistein and some isoflavone metabolites reduce the activity of 25-D3-24-hydroxylase (CYP24) in the human prostate cancer-derived cell line DU-145. CYP24 is also responsible for degradation of the active vitamin D metabolite 1,25-dihydroxyvitamin D3 which is known to be antimitotic and prodifferentiating in prostate cancer cells. High levels of CYP24 frequently found in prostate cancer cells may thus degrade the active metabolite. This could be prevented by ingestion of genistein-containing food such as soybeans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270218     DOI: 10.1016/s1570-0232(02)00081-8

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.

Authors:  Shuping Shuai; Shanlan Yue; Qingting Huang; Wei Wang; Junyi Yang; Ke Lan; Liming Ye
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-02-11       Impact factor: 2.441

2.  Biochanin A inhibits breast cancer tumor growth in a murine xenograft model.

Authors:  Young Jin Moon; Beom Soo Shin; Guohua An; Marilyn E Morris
Journal:  Pharm Res       Date:  2008-05-03       Impact factor: 4.200

3.  Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation.

Authors:  Christopher D Gardner; Beibei Oelrich; Jenny P Liu; David Feldman; Adrian A Franke; James D Brooks
Journal:  Prostate       Date:  2009-05-15       Impact factor: 4.104

4.  Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.

Authors:  Srilatha Swami; Aruna V Krishnan; Jacqueline Moreno; Rumi S Bhattacharyya; Christopher Gardner; James D Brooks; Donna M Peehl; David Feldman
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

Review 5.  Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME.

Authors:  Zhen Yang; Kaustubh Kulkarni; Wei Zhu; Ming Hu
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.